Media Releases and Opportunities
» Go to news mainMedia opportunity: Dalhousie University researcher wins top prize for paper on her innovative research showing that reversing insulin resistance improves psychiatric outcomes in treatment‑resistant bipolar disorder
Dalhousie University physician Dr. Cindy Calkin is being honoured with a top psychiatry award for research that discovered a new way to address treatment-resistant bipolar disorder – by reversing insulin resistance. It is a novel approach that involves treating an underlying metabolic disorder to improve a psychiatric one, a concept that led to a paradigm shift in the field of psychiatry.
Dr. Calkin, a clinical researcher and associate professor of Psychiatry and Medical Neuroscience, will receive the 2023 Paul Wender Best Paper in The Journal of Clinical Psychiatry Award for her paper, Treating Insulin Resistance with Metformin as a Strategy to Improve Outcome in Treatment-Resistant Bipolar Disorder - the TRIO-BD study. It was selected by the American Society of Clinical Psychopharmacology Awards Committee.
The study showed that reversing insulin resistance improved treatment-resistant bipolar depression in patients who had been chronically ill for more than 25 years and failed eight to nine psychiatric medication trials over their lifetime. Their improvement was significant within six weeks of starting the drug Metformin, with patients remaining well throughout the 26-week trial.
Dr. Calkin and her team were the first to find high rates of insulin resistance in patients with bipolar disorder and that insulin resistance was independently linked to negative bipolar outcomes. As a result, the Canadian Diabetes Association updated its guidelines to include bipolar disorder as an independent risk factor for Type 2 diabetes. Dr. Calkin and her team have also published guidelines recommending that all patients with bipolar disorder be tested for insulin resistance.
Dr. Calkin is available to discuss her research, the award being presented today and how this work has given hope to even the sickest of those affected.
-30-
Media contact:
Alison Auld
Senior Research Reporter
Communications, Marketing and Creative Services
Dalhousie University
Cell: 1-902-220-0491
Email: alison.auld@dal.ca
Recent News
- Media release: Dalhousie University recognizes six individuals with honorary degrees
- Media release: New $4.3 million grant powers partnership between Atlantic First Nations Water Authority and Dalhousie University to deliver world‑class water treatment
- Media release: More than half of global branded plastic pollution linked to just 56 companies: international research project
- Media opportunity: Researchers reveal the critical role metabolism plays in reducing the risk of frailty in older adults and how the two are closely linked
- Press Release ‑ Introducing Dalhousie University’s 2024 Board of Governors' Award winners
- Media opportunity: Repeated, small hits to the heads of football players may damage the small blood vessels of the brain: Dalhousie University research
- Media release: Dalhousie‑led initiative awarded $1.9M in federal funding to help agriculture sector meet emission reduction targets
- Dalhousie announces launch of Bringing Worlds Together—a $750‑million campaign for transformational change
Comments
comments powered by Disqus